おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
NIF SMBC Ventures
About
NIF SMBC Ventures USA, Inc. is out of business. It is a venture capital firm specializing in investments at any stage of company
- Palo Alto,California,United States
Highlights
Details
- Operating Status
- Active
- Investor Type
- Venture Capital
NIF SMBC Ventures USA, Inc. is out of business. It is a venture capital firm specializing in investments at any stage of company development with a focus on earlier round financings. It typically invests between $1 million and $10 million in its portfolio companies. The firm’s investments tend to spread over several rounds of financing. It looks for products and services that addressed large emerging markets with the potential to be at least $100 million in a few years and more. The firm seeks to take a board seat in its portfolio companies. NIF SMBC Ventures USA, Inc. was founded in 1996 and is based in Palo Alto, California.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 11, 2008
Gene Techno Science
|
Series Unknown | ¥500.25M | Biopharma | — |
|
May 6, 2008
REGiMMUNE
|
Series B | $8M | Biopharma | — |
|
Feb 1, 2008
REGiMMUNE
|
Series B | $6M | Biopharma | Yes |
|
Jul 3, 2007
Diatos
|
Series D | $12.80M | Biotechnology | — |
|
Feb 21, 2007
REGiMMUNE
|
Series A | $4.20M | Biopharma | Yes |
Exits
NIF SMBC Ventures has had 6 exits. NIF SMBC Ventures most notable exits include eSilicon , Innate Pharma
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Nov 11, 2019 | eSilicon | M&A | Computer | Detail |
| Oct 17, 2019 | Innate Pharma | IPO | Biopharma | Detail |
| Apr 2, 2015 | Abionyx Pharma | IPO | Biotechnology | Detail |
| Nov 30, 2012 | Gene Techno Science | M&A | Biopharma | Detail |
| Dec 23, 2009 | Novexel | M&A | Biotechnology | Detail |
